BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23538390)

  • 21. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.
    Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y
    Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19.
    Lin H; Lin T; Lin J; Yang M; Shen Z; Liu H; Zou Z; Zheng Z
    Gene; 2019 Mar; 688():93-97. PubMed ID: 30415005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
    Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
    Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
    Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
    Guo Z; He C; Yang F; Qin L; Lu X; Wu J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-124 represses wound healing by targeting SERP1 and inhibiting the Wnt/β-catenin pathway.
    Zhang G; Song K; Yan H
    Adv Clin Exp Med; 2019 Jun; 28(6):711-718. PubMed ID: 30740945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer.
    Li X; Li J; Cai Y; Peng S; Wang J; Xiao Z; Wang Y; Tao Y; Li J; Leng Q; Wu D; Yang S; Ji Z; Han Y; Li L; Gao X; Zeng C; Wen X
    Cancer Lett; 2018 Apr; 418():211-220. PubMed ID: 29331421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-151 regulates the growth, chemosensitivity and metastasis of human prostate cancer cells by targeting PI3K/AKT.
    Chen S; Ke S; Cheng S; Wu T; Yang Y; Liao B
    J BUON; 2020; 25(4):2045-2050. PubMed ID: 33099951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.
    Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY
    Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
    Zhang X; Pan Y; Fu H; Zhang J
    Med Sci Monit; 2019 Feb; 25():1122-1132. PubMed ID: 30741252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
    Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.
    Hong X; Yu JJ
    Am J Physiol Cell Physiol; 2019 Apr; 316(4):C463-C480. PubMed ID: 30566393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2201-2210. PubMed ID: 28741117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
    Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.
    Thudi NK; Martin CK; Murahari S; Shu ST; Lanigan LG; Werbeck JL; Keller ET; McCauley LK; Pinzone JJ; Rosol TJ
    Prostate; 2011 May; 71(6):615-25. PubMed ID: 20957670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.
    Han G; Fan M; Zhang X
    Biochem Biophys Res Commun; 2015 Jan; 456(3):804-9. PubMed ID: 25511701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.